Cocrystal Pharma, Inc. Annual Nonoperating Income (Expense) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cocrystal Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
  • Cocrystal Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $103K, a 63% decline year-over-year.
  • Cocrystal Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $612K.
  • Cocrystal Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was $575K.
  • Cocrystal Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was -$8K, a 122% decline from 2021.
  • Cocrystal Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $36K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $575K +$583K Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$8K -$44K -122% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $36K +$98K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 -$62K -$299K -126% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 $237K -$57K -19.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 $294K -$475K -61.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $769K -$782K -50.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $1.55M +$13M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-21
2015 -$11.4M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.